Terms: = Prostate cancer AND FBXW7, AGO, 55294, ENSG00000109670, FLJ11071, SEL-10, CDC4, FBXW6, SEL10, FBW7, DKFZp686F23254, FBX30 AND Staging
14 results:
1. Intense 18 F-PSMA-1007 Uptake of Splenic Hemangioma.
Jia G; Dong A; Cheng C; Zuo C
Clin Nucl Med; 2024 Feb; 49(2):e90-e92. PubMed ID: 38048527
[TBL] [Abstract] [Full Text] [Related]
2. Primary resection of oligometastatic recurrent prostatic carcinoma in the urethra.
Foo MA; Lim EJ; Cheng CWS; Ng LG
BMJ Case Rep; 2022 Sep; 15(9):. PubMed ID: 36130819
[TBL] [Abstract] [Full Text] [Related]
3.
Uprimny C
Wien Med Wochenschr; 2019 Feb; 169(1-2):3-11. PubMed ID: 28577076
[TBL] [Abstract] [Full Text] [Related]
4. PET and PET/CT with radiolabeled choline in prostate cancer: a critical reappraisal of 20 years of clinical studies.
Giovacchini G; Giovannini E; Leoncini R; Riondato M; Ciarmiello A
Eur J Nucl Med Mol Imaging; 2017 Sep; 44(10):1751-1776. PubMed ID: 28409220
[TBL] [Abstract] [Full Text] [Related]
5. Revisiting the human seminiferous epithelium cycle.
Nihi F; Gomes MLM; Carvalho FAR; Reis AB; Martello R; Melo RCN; Almeida FRCL; Chiarini-Garcia H
Hum Reprod; 2017 Jun; 32(6):1170-1182. PubMed ID: 28369509
[TBL] [Abstract] [Full Text] [Related]
6. prostate-Specific Antigen (PSA)-Based Population Screening for prostate cancer: An Economic Analysis.
Tawfik A
Ont Health Technol Assess Ser; 2015; 15(11):1-37. PubMed ID: 26366237
[TBL] [Abstract] [Full Text] [Related]
7. [Incidental undifferentiated carcinoma of the prostate: A case with unusual diagnosis].
Baunacke M; Toma M; Novotny V; Fröhner M; Wirth M; Huber J
Urologe A; 2015 Nov; 54(11):1602-5. PubMed ID: 25301238
[TBL] [Abstract] [Full Text] [Related]
8. Metastatic prostate cancer proven by 18F-FCH PET/CT staging scan in patient with normal PSA but high PSA doubling time.
Hodolič M; Maffione AM; Fettich J; Gubina B; Cimitan M; Rubello D
Clin Nucl Med; 2013 Sep; 38(9):739-40. PubMed ID: 23816948
[TBL] [Abstract] [Full Text] [Related]
9. Anatomy of the anterior prostate and extraprostatic space: a contemporary surgical pathology analysis.
Fine SW; Al-Ahmadie HA; Gopalan A; Tickoo SK; Scardino PT; Reuter VE
Adv Anat Pathol; 2007 Nov; 14(6):401-7. PubMed ID: 18049129
[TBL] [Abstract] [Full Text] [Related]
10. Technology insight: monoclonal antibody imaging of prostate cancer.
Bander NH
Nat Clin Pract Urol; 2006 Apr; 3(4):216-25. PubMed ID: 16607370
[TBL] [Abstract] [Full Text] [Related]
11. Predicting pelvic lymph node involvement in patients with localized prostate cancer.
Ekman P
Eur Urol; 1997; 32 Suppl 3():60-4. PubMed ID: 9267787
[TBL] [Abstract] [Full Text] [Related]
12. [Benign and malignant diseases of the prostate].
Grond A; Ostermann-Myrau M
Versicherungsmedizin; 1994 Dec; 46(6):199-205. PubMed ID: 7529955
[TBL] [Abstract] [Full Text] [Related]
13. [cancer of the prostate: current diagnostic aspects].
Sanz Velez JI; Gil Sanz MJ; Allepuz Losa C; Rioja Sanz LA
Actas Urol Esp; 1991; 15(6):518-26. PubMed ID: 1724346
[TBL] [Abstract] [Full Text] [Related]
14. Prostatic cancer revisited.
Cosgrove MD; Kaempf MJ
J Urol; 1976 Jan; 115(1):79-81. PubMed ID: 813018
[TBL] [Abstract] [Full Text] [Related]
